Garduño-Sanchez, SVillanego-Beltran, Ide Las Peñas-Cabrera, M DoloresJaen-Olasolo, J2023-05-032023-05-032021-06-07Garduño-Sánchez S, Villanego-Beltrán I, de Las Peñas-Cabrera MD, Jaén-Olasolo J. Comparison between Accelerated Partial Breast Irradiation with multicatheter interstitial brachytherapy and Whole Breast Irradiation, in clinical practice. Clin Transl Oncol. 2022 Jan;24(1):24-33http://hdl.handle.net/10668/20986The aim of this study was to compare accelerated partial breast irradiation (APBI) with multicatheter interstitial brachytherapy (BT) and whole breast irradiation (WBI), in terms of toxicity, aesthetic result, quality of life and survival, in clinical practice. A comparative study of two prospectively recorded cohorts of 76 breast cancer patients who complied with the recommendations of GEC-ESTRO for APBI was conducted. The main objective was toxicity, quality of life measured through validated questionnaires and the aesthetic results. Secondary objectives were overall survival and disease-free survival. Seventy-six stage I/II breast cancer patients, with a mean age of 66 years entered the study. APBI group showed less acute G1-2 dermatitis (51.4 vs 94.9%, p  APBI is an attractive alternative in candidate patients with initial breast cancer, with benefits in acute toxicity and quality of life and fewer visits to the hospital, without compromising tumor control or survival.enAccelerated partial breast irradiationBrachytherapyBreastCancerAgedBrachytherapyBreast neoplasmsCathetersDisease-free survivalFemaleHumansMiddle agedQuality of lifeRadiotherapyRetrospective studiesSurvival rateTreatment outcomeresearch article34213744open accessBraquiterapiaCalidad de vidaNeoplasias de la mamaRadioterapiaResultado del tratamientoSupervivencia sin enfermedadTasa de supervivencia10.1007/s12094-021-02664-z1699-3055PMC8251685https://link.springer.com/content/pdf/10.1007/s12094-021-02664-z.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251685/pdf